FAF could be a useful tool for SC and SLC

Article

Fundus autofluorescence (FAF) imaging could be a useful tool for assessing patients with serpiginous choroidopathy (SC) and serpiginous-like choroidopathy (SLC).

Fundus autofluorescence (FAF) imaging could be a useful tool for assessing patients with serpiginous choroidopathy (SC) and serpiginous-like choroidopathy (SLC), according to a paper published in the journal Eye.

Dr E. Carreno et al., Department of Ophthalmology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain, conducted a prospective case series on 12 patients with SC and SLC. All patients experienced FAF imaging from July 2009 to December 2010.

There was bilateral involvement in nine cases and three different FAF imaging patterns were revealed. This included active inflammation, transitional and inactive inflammation.

FAF can be a helpful tool for imaging SC and SLC patients and it may be possible to reserve other invasive technique. For example FA could be used for patients with suspicious activity disclosed by FAF imaging.

The abstract can be found here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.